Reyes A J
Departamento de Investigación Cardiovascular, Fundación Procardias, Montevideo, Uruguay.
Arzneimittelforschung. 1988 Jan;38(1A):194-9.
A formal comparison is carried out of the antihypertensive effect of torasemide (1-isopropyl-3- ([4-(3-methylphenylamino)pyridine]-3-sulfonyl)urea) and various other diuretics used as monotherapy. The analyzed data are the results of various independent studies. The time (t) courses of the mean values of supine or sitting systolic (S) and diastolic (D) arterial blood pressure (P) during treatment are analyzed by fitting the "Montevideo mathematical model", described here, to the clinical (experimental) data. Clinically-important values of P and t evaluated from the fitted functions permit the formal comparisons. Decays in P were evaluated by the reductions in SP and DP occurred at 1.17 and 7.54 weeks of treatment, by the times at which the fitted functions showed diminutions of 10, 15 and 20 mmHg and of 10%, 15% and 20% with respect to pretreatment SP and DP mean values, and by the time at which DP attained a value of 90 mmHg. In studies in which the pretreatment mean value of DP ranged between 105.6 and 110.5 mmHg, standard-dose indapamide (2.5 to 5 mg/d), and low-dose torasemide (2.5 to 5 mg/d) elicited similar decays in SP and DP; the antihypertensive effects of etozoline (200 to 400 mg/d) and of hydrochlorothiazide (25 to 50 mg/d) were slower than those of torasemide and indapamide. Cyclothiazide (5 mg/d) and a coprescribed sodium-restricted diet reduced DP, from a pretreatment mean value of 114 mmHg, slower than torasemide and indapamide but quicker than etozoline and hydrochlorothiazide. Torasemide and indapamide should be consequently preferred for the chronic treatment of uncomplicated essential hypertension in terms of efficacy.(ABSTRACT TRUNCATED AT 250 WORDS)
对托拉塞米(1-异丙基-3-([4-(3-甲基苯基氨基)吡啶]-3-磺酰基)脲)与用作单一疗法的其他各种利尿剂的降压效果进行了正式比较。分析的数据是各种独立研究的结果。通过将此处描述的“蒙得维的亚数学模型”拟合到临床(实验)数据,分析治疗期间仰卧位或坐位收缩压(S)和舒张压(D)动脉血压(P)平均值的时间(t)过程。从拟合函数评估的P和t的临床重要值允许进行正式比较。通过治疗1.17周和7.54周时SP和DP的降低、拟合函数相对于治疗前SP和DP平均值显示降低10、15和20 mmHg以及降低10%、15%和20%的时间,以及DP达到90 mmHg的时间来评估P的下降。在DP治疗前平均值介于105.6和110.5 mmHg之间的研究中,标准剂量吲达帕胺(2.5至5 mg/d)和低剂量托拉塞米(2.5至5 mg/d)引起的SP和DP下降相似;依他唑啉(200至400 mg/d)和氢氯噻嗪(25至50 mg/d)的降压作用比托拉塞米和吲达帕胺慢。环噻嗪(5 mg/d)和共同规定的限钠饮食使DP从治疗前平均值114 mmHg开始降低,比托拉塞米和吲达帕胺慢,但比依他唑啉和氢氯噻嗪快。因此,就疗效而言,托拉塞米和吲达帕胺应更适合用于单纯性原发性高血压的慢性治疗。(摘要截短于250字)